Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 1 | BMC Medical Research Methodology

Figure 1

From: Reporting of loss to follow-up information in randomised controlled trials with time-to-event outcomes: a literature survey

Figure 1

Recalculation of the numbers at risk - example classified as "consistent". Kaplan-Meier plot of a randomised trial comparing prednisolone and a control group [4]. According to the information in the text of the publication, one patient was lost to follow-up in the prednisolone group and minimum follow-up was 120 days. At one time point beforehand (90 days), we read the survival probability from the curve (see vertical line). We recalculated the number of patients at risk by multiplying the survival probability with the number of randomised patients (number at risk: 17 in the prednisolone group vs. 6 in the control group). As the calculated and reported numbers matched (taking into account the one patient lost to follow-up in the prednisolone group), this example would be classified as "consistent".

Back to article page